Reference distributions for alpha2‐macroglobulin: A practical, simple and clinically relevant approach in a large cohort
- 1 January 2004
- journal article
- research article
- Published by Wiley in Journal of Clinical Laboratory Analysis
- Vol. 18 (2) , 139-147
- https://doi.org/10.1002/jcla.20012
Abstract
In this 11th article in a series, reference values of serum levels alpha2-macroglobulin α2M) are examined. The study is based on a cohort of 40,420 Caucasian individuals from northern New England that were tested in our laboratory between 1994 and 2000. Measurements were standardized against Certified Reference Material (CRM 470)/Reference Preparation for Proteins in Human Serum (RPPHS) and the results analyzed using a previously described statistical approach. Individuals with unequivocal laboratory evidence of inflammation (C-reactive protein >10 mg/L) were excluded in one leg of the study and included in the other, confirming that α2M does not respond to acute phase drive in man. Nephrotic syndrome, diabetes mellitus, and chronic liver disease have significant effect on levels of α2M. Dramatic changes occur during life with males higher from birth to age 12, females thereafter have higher values until the ninth decade. When values were expressed as multiples of the age- and gender-specific median levels, the resulting distributions fitted a log-Gaussian distribution well over a broad range. When patient data are normalized in this manner, the distribution parameters can be used to assign a centile corresponding to an individual's measurement thus simplifying interpretation. J. Clin. Lab. Anal. 18:139–147, 2004.Keywords
This publication has 75 references indexed in Scilit:
- Reference distributions for α2‐macroglobulin: A comparison of a large cohort to the world's literatureJournal of Clinical Laboratory Analysis, 2004
- Management of steroid-sensitive nephrotic syndrome in children with type 1 diabetesPediatric Nephrology, 2002
- Genetic association of ?2-macroglobulin with Alzheimer's disease in a Finnish elderly populationAnnals of Neurology, 1999
- Remission of nephrotic syndrome in type 1 diabetes: Long-term follow-up of patients in the Captopril StudyAmerican Journal of Kidney Diseases, 1999
- Plasma α2 macroglobulin is increased in nephrotic patients as a result of increased synthesis aloneKidney International, 1998
- α2‐Macroglobulin as a β‐Amyloid Peptide‐Binding Plasma ProteinJournal of Neurochemistry, 1997
- Alpha-2-macroglobulin and hepatic fibrosisDigestive Diseases and Sciences, 1994
- Structure of the human alpha-2 macroglobulin gene and its promotorBiochemical and Biophysical Research Communications, 1992
- Reduced trypsin binding capacity of α2-macroglobulin in diabetesClinica Chimica Acta; International Journal of Clinical Chemistry, 1986
- Alpha2-Macroglobulin and Proliferative Retinopathy in Type 1 DiabetesHormone and Metabolic Research, 1982